These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2445085)

  • 1. Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506.
    Ochiai T; Hamaguchi K; Isono K
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):93-7. PubMed ID: 2445085
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.
    Thiru S; Collier DS; Calne R
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):98-9. PubMed ID: 2445086
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolongation of canine renal allograft survival by treatment with FK-506.
    Ochiai T; Nagata M; Nakajima K; Sakamoto K; Asano T; Isono K
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):53-6. PubMed ID: 2445075
    [No Abstract]   [Full Text] [Related]  

  • 4. Kidney transplantation in the dog receiving FK-506.
    Collier DS; Thiru S; Calne R
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):62. PubMed ID: 2445077
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations about FK-506 in primates.
    Calne R; Collier DS; Thiru S
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):63. PubMed ID: 2445078
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterotopic heart transplantation in the rat receiving FK-506.
    Lim SM; Thiru S; White DJ
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):68-70. PubMed ID: 2445080
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506.
    Kobayashi C; Kanai A; Nakajima A; Okumura K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3156-8. PubMed ID: 2468254
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the effects of FK506 on renal allografting in the beagle dog.
    Ochiai T; Nagata M; Nakajima K; Suzuki T; Sakamoto K; Enomoto K; Gunji Y; Uematsu T; Goto T; Hori S
    Transplantation; 1987 Dec; 44(6):729-33. PubMed ID: 2447688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oral dosage form of FK-506.
    Honbo T; Kobayashi M; Hane K; Hata T; Ueda Y
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):17-22. PubMed ID: 2445068
    [No Abstract]   [Full Text] [Related]  

  • 10. Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
    Todo S; Demetris AJ; Ueda Y; Imventarza O; Okuda K; Casavilla A; Cemaj S; Ghalab A; Mazzaferro V; Rhoe BS
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):57-61. PubMed ID: 2445076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on FK506 in experimental organ transplantation.
    Ochiai T; Sakamoto K; Nagata M; Nakajima K; Goto T; Hori S; Kenmochi T; Nakagori T; Asano T; Isono K
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):209-14. PubMed ID: 2450414
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443.
    Gunji Y; Ochiai T; Sakamoto K; Suzuki T; Nagata M; Nakajima K; Komori A; Asano T; Isono K; Hamaguchi K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):752-3. PubMed ID: 7679841
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK-506 in experimental renal allografts.
    Collier DS; Calne R; Thiru S; Friend PJ; Lim S; White DJ; Kohno H; Levickis J
    Transplant Proc; 1987 Oct; 19(5):3975-7. PubMed ID: 2445063
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus based immunosuppression.
    First MR
    J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine in transplantation of the liver in the dog.
    Williams JW; Peters TG; Haggitt R; Van Voorst S
    Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticoduodenal allotransplantation with FK 506 in the dog.
    Morimoto T; Yamada F; Kobayashi T; Miyaishi S; Tokumaru T; Kamiya I; Takagi H
    Transplant Proc; 1990 Apr; 22(2):717-9. PubMed ID: 1691550
    [No Abstract]   [Full Text] [Related]  

  • 20. FK-506--how much potential?
    Thomson AW
    Immunol Today; 1989 Jan; 10(1):6-9. PubMed ID: 2473767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.